Form DEFA14A Day One Biopharmaceutica
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
|
Check the appropriate box:
|
|||
|
☐
|
| |
Preliminary Proxy Statement
|
|
☐
|
| |
Confidential, for Use of the Commission Only (as
permitted by Rule 14a-6(e)(2))
|
|
☐
|
| |
Definitive Proxy Statement
|
|
☒
|
| |
Definitive Additional Materials
|
|
☐
|
| |
Soliciting Material under §240.14a-12
|
DAY ONE BIOPHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
Payment of Filing Fee (Check all boxes that apply):
|
|||
|
☒
|
| |
No fee required.
|
|
☐
|
| |
Fee paid previously with preliminary materials.
|
|
☐
|
| |
Fee computed on table in exhibit required by Item 25(b) per Exchange
Act Rules 14a-6(i)(1) and 0-11.
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecopetrol announces the dates for the presentation of its second quarter 2026 results report and conference call
- China-CEEC trade rises 11% in first half, customs data shows
- FPT Launches MediSight Framework to Accelerate AI-Driven Healthcare and Life Sciences Innovation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share